Alissa Mun
Health Scientist Policy Analyst
U.S. Food & Drug Administration
Alissa Mun is a Health Scientist Policy Analyst in the Division of Clinical Trial Quality at FDA/CDER, where she leads initiatives to improve clinical trial design, oversight, and quality. With over 20 years of experience spanning regulatory, sponsor, and CRO environments, Alissa brings a systems-thinking approach to risk-based monitoring, Quality by Design, and trial efficiency. In addition to her regulatory leadership, Alissa is deeply committed to professional development and mentoring. She regularly shares strategies to help professionals at all career stages build confidence, develop clarity around their contributions, and navigate complex roles in clinical research. Known for her thoughtful guidance and approachable style, Alissa blends policy expertise with practical insights to support individual growth within high-stakes environments. Her dual focus on regulatory innovation and talent development makes her a trusted voice for those seeking both operational excellence and career fulfillment in the clinical research ecosystem.